 |
 |
|
 |
EKR Therapeutics is a specialty pharmaceutical company, founded in Nov 2005 focusing on identifying, fostering and targeting the growth of products to serve the needs of the acute-care hospital setting. EKR was acquired by Cornerstone Therapeutics (NASDAQ CRTX) for $ 150 MM in 2012.
|
|
|
ESP Chinapharma is a specialty pharma company focusing on registration, sales and marketing of pharmaceutical products in China market. It currently has six products in registration in China, and is the distributor of Pharmascience, a leading Canadian pharmaceutical company. |
|
 |
ESP Pharma. A specialty pharmaceutical company founded in 2002, voted Top 100 company by Venture Reporter, reached $ 90MM revenue in 2004, and sold to Protein Design Labs (NASDAQ: PDLI) for more than $ 500 million dollars in January 2005. Protein Design Labs, Inc. (PDL) is a leading developer of humanized monoclonal
antibody drugs. |
|
|
